A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181-Reference-Cited by-同舟云学术

A Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Development of ECOG-ACRIN EA5181

Published:2022-11 Issue:7 Volume:23 Page:547-560
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Varlotto John Michael^ORCID,Sun Zhuoxin,Ky Bonnie,Upshaw Jenica,Fitzgerald Thomas J.,Diehn Max,Lovly Christine,Belani Chandra,Oettel Kurt,Masters Gregory,Harkenrider Matthew,Ross Helen,Ramalingam Suresh,Pennell Nathan A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference110 articles.

1. Cancer statistics, 2018;Siegel;CA: a Cancer Journal for Clinicians,2018

2. Long-term results of NRG Oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small cell lung cancer;Bradley;J Clin Oncol,2020

3. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial;Rosenman;Int J Rad Oncol Biol Phys,2002

4. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung: preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

5. Accelerated hypofractionated image-guided vs conventional radiotherapy for patients with stage II/III non-small cell lung cancer and poor performance status: a randomized trial;Iyengar;JAMA Oncol,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy;Journal of the National Cancer Center;2024-06

2. A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-12

3. Mechanistic rationales for combining immunotherapy with radiotherapy;Frontiers in Immunology;2023-06-12